Fatal breakthrough infection with Fusarium andiyazi: New multi-resistant aetiological agent cross-reacting with Aspergillus galactomannan enzyme immunoassay
dc.contributor.author | van Diepeningen, Anne D. | |
dc.contributor.author | Meijer, Martin | |
dc.contributor.author | Al-Hatmi, Abdullah M.S. | |
dc.contributor.buuauthor | Kebabçı, Nesrin | |
dc.contributor.buuauthor | Ener, Beyza | |
dc.contributor.buuauthor | Ersal, Tuba | |
dc.contributor.buuauthor | Özkocaman, Vildan | |
dc.contributor.buuauthor | Ursavaş, Ahmet | |
dc.contributor.buuauthor | Çetinoğlu, Ezgi Demirdöğen | |
dc.contributor.buuauthor | Akalın, Halis | |
dc.contributor.department | Uludağ Üniversitesi/Tıp Fakültesi/Enfeksiyon Hastalıkları ve Klinik Mikrobiyoloji Anabilim Dalı. | tr_TR |
dc.contributor.department | Uludağ Üniversitesi/Tıp Fakültesi/Tıbbi Mikrobiyoloji Anabilim Dalı. | tr_TR |
dc.contributor.department | Uludağ Üniversitesi/Tıp Fakültesi/İç Hastalıkları Anabilim Dalı. | tr_TR |
dc.contributor.department | Uludağ Üniversitesi/Tıp Fakültesi/Göğüs Hastalıkları Anabilim Dalı. | tr_TR |
dc.contributor.orcid | 0000-0002-4803-8206 | tr_TR |
dc.contributor.researcherid | AAJ-4354-2021 | tr_TR |
dc.contributor.researcherid | AAI-3169-2021 | tr_TR |
dc.contributor.researcherid | AAH-1854-2021 | tr_TR |
dc.contributor.researcherid | AAG-8523-2021 | tr_TR |
dc.contributor.researcherid | AAU-8952-2020 | tr_TR |
dc.contributor.scopusid | 56060994000 | tr_TR |
dc.contributor.scopusid | 15053025300 | tr_TR |
dc.contributor.scopusid | 56061031700 | tr_TR |
dc.contributor.scopusid | 6603145040 | tr_TR |
dc.contributor.scopusid | 8329319900 | tr_TR |
dc.contributor.scopusid | 57189524206 | tr_TR |
dc.contributor.scopusid | 57207553671 | tr_TR |
dc.date.accessioned | 2022-09-13T06:46:54Z | |
dc.date.available | 2022-09-13T06:46:54Z | |
dc.date.issued | 2014-04 | |
dc.description.abstract | Disseminated infections caused by members of the Fusarium fujikuroi species complex (FFSC) occur regularly in immunocompromised patients. Here, we present the first human case caused by FFSC-member Fusarium andiyazi. Fever, respiratory symptoms and abnormal computerised tomography findings developed in a 65-year-old man with acute myelogenous leukaemia who was under posaconazole prophylaxis during his remission-induction chemotherapy. During the course of infection, two consecutive blood galactomannan values were found to be positive, and two blood cultures yielded strains resembling Fusarium species, according to morphological appearance. The aetiological agent proved to be F. andiyazi based on multilocus sequence typing. The sequencing of the internal transcribed spacer region did not resolve the closely related members of the FFSC, but additional data on partial sequence of transcription elongation factor 1 alpha subunit did. A detailed morphological study confirmed the identification of F. andiyazi, which had previously only been reported as a plant pathogen affecting various food crops. | en_US |
dc.identifier.citation | Kebabçı, N. vd. (2014). "Fatal breakthrough infection with Fusarium andiyazi: New multi-resistant aetiological agent cross-reacting with Aspergillus galactomannan enzyme immunoassay". Mycoses, 57(4), 249-255. | en_US |
dc.identifier.endpage | 255 | tr_TR |
dc.identifier.issn | 0933-7407 | |
dc.identifier.issn | 1439-0507 | |
dc.identifier.issue | 4 | tr_TR |
dc.identifier.pubmed | 24612042 | tr_TR |
dc.identifier.scopus | 2-s2.0-84895819003 | tr_TR |
dc.identifier.startpage | 249 | tr_TR |
dc.identifier.uri | https://doi.org/10.1111/myc.12142 | |
dc.identifier.uri | https://onlinelibrary.wiley.com/doi/full/10.1111/myc.12142 | |
dc.identifier.uri | http://hdl.handle.net/11452/28654 | |
dc.identifier.volume | 57 | tr_TR |
dc.identifier.wos | 000332414900009 | tr_TR |
dc.indexed.pubmed | PubMed | en_US |
dc.indexed.scopus | Scopus | en_US |
dc.indexed.wos | SCIE | en_US |
dc.language.iso | en | en_US |
dc.publisher | Wiley | en_US |
dc.relation.collaboration | Yurt dışı | tr_TR |
dc.relation.journal | Mycoses | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi | tr_TR |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Acute leukaemia | en_US |
dc.subject | Posaconazole prophylaxis | en_US |
dc.subject | Fusarium andiyazi | en_US |
dc.subject | Fusarium fujikuroi species complex | en_US |
dc.subject | Galactomannan | en_US |
dc.subject | Breakthrough infections | en_US |
dc.subject | DNA-sequence database | en_US |
dc.subject | Posaconazole prophylaxis | en_US |
dc.subject | European organization | en_US |
dc.subject | Leukemia | en_US |
dc.subject | Diagnosis | en_US |
dc.subject | Disease | en_US |
dc.subject | Patient | en_US |
dc.subject | Assay | en_US |
dc.subject | Rice | en_US |
dc.subject | Dermatology | en_US |
dc.subject | Mycology | en_US |
dc.subject.emtree | Amphotericin B | en_US |
dc.subject.emtree | Amphotericin B lipid complex | en_US |
dc.subject.emtree | Antineoplastic agent | en_US |
dc.subject.emtree | Caspofungin | en_US |
dc.subject.emtree | Cefoperazone plus sulbactam | en_US |
dc.subject.emtree | Clarithromycin | en_US |
dc.subject.emtree | Cotrimoxazole | en_US |
dc.subject.emtree | Fluconazole | en_US |
dc.subject.emtree | Galactomannan | en_US |
dc.subject.emtree | Internal transcribed spacer | en_US |
dc.subject.emtree | Itraconazole | en_US |
dc.subject.emtree | Micafungin | en_US |
dc.subject.emtree | Piperacillin plus tazobactam | en_US |
dc.subject.emtree | Posaconazole | en_US |
dc.subject.emtree | Transcription elongation factor | en_US |
dc.subject.emtree | Acute granulocytic leukemia | en_US |
dc.subject.emtree | Aged | en_US |
dc.subject.emtree | Alpha chain | en_US |
dc.subject.emtree | Antifungal susceptibility | en_US |
dc.subject.emtree | Article | en_US |
dc.subject.emtree | Aspergillus | en_US |
dc.subject.emtree | Blood culture | en_US |
dc.subject.emtree | Cancer chemotherapy | en_US |
dc.subject.emtree | Cancer regression | en_US |
dc.subject.emtree | Case report | en_US |
dc.subject.emtree | Chemoprophylaxis | en_US |
dc.subject.emtree | Community acquired pneumonia | en_US |
dc.subject.emtree | Computer assisted tomography | en_US |
dc.subject.emtree | Cross reaction | en_US |
dc.subject.emtree | Disease course | en_US |
dc.subject.emtree | Drug substitution | en_US |
dc.subject.emtree | Drug withdrawal | en_US |
dc.subject.emtree | Enzyme immunoassay | en_US |
dc.subject.emtree | Fever | en_US |
dc.subject.emtree | Fungus growth | en_US |
dc.subject.emtree | Fungus identification | en_US |
dc.subject.emtree | Fusariosis | en_US |
dc.subject.emtree | Fusarium | en_US |
dc.subject.emtree | Fusarium andiyazi | en_US |
dc.subject.emtree | Gene sequence | en_US |
dc.subject.emtree | Human | en_US |
dc.subject.emtree | Induction chemotherapy | en_US |
dc.subject.emtree | Male | en_US |
dc.subject.emtree | Micromorphology | en_US |
dc.subject.emtree | Multilocus sequence typing | en_US |
dc.subject.emtree | Nucleotide sequence | en_US |
dc.subject.emtree | Priority journal | en_US |
dc.subject.emtree | Respiratory tract disease | en_US |
dc.subject.emtree | Thorax radiography | en_US |
dc.subject.emtree | Unspecified side effect | en_US |
dc.subject.mesh | Aged | en_US |
dc.subject.mesh | Antigens, fungal | en_US |
dc.subject.mesh | Aspergillus | en_US |
dc.subject.mesh | Cross reactions | en_US |
dc.subject.mesh | Diagnosis, differential | en_US |
dc.subject.mesh | DNA, fungal | en_US |
dc.subject.mesh | DNA, ribosomal spacer | en_US |
dc.subject.mesh | Fusariosis | en_US |
dc.subject.mesh | Fusarium | en_US |
dc.subject.mesh | Humans | en_US |
dc.subject.mesh | Immunoenzyme techniques | en_US |
dc.subject.mesh | Leukemia, myeloid, acute | en_US |
dc.subject.mesh | Male | en_US |
dc.subject.mesh | Mannans | en_US |
dc.subject.mesh | Multilocus sequence typing | en_US |
dc.subject.mesh | Tomography, X-ray computed | en_US |
dc.subject.scopus | Species Complex; Fusarium Incarnatum; Chlamydospores | en_US |
dc.subject.wos | Dermatology | en_US |
dc.subject.wos | Mycology | en_US |
dc.title | Fatal breakthrough infection with Fusarium andiyazi: New multi-resistant aetiological agent cross-reacting with Aspergillus galactomannan enzyme immunoassay | en_US |
dc.type | Article | |
dc.wos.quartile | Q2 | en_US |
Files
License bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- license.txt
- Size:
- 1.71 KB
- Format:
- Item-specific license agreed upon to submission
- Description: